SCHEMBL8284617

SCHEMBL8284617

Cc1nc(C)c(Cn2c(N)nc3cc(CO)ccc32)nc1C

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RPS6KA5 O75582 1/20 0.47
▸ HTT P42858 3/20 0.43
▸ ALDH1A1 P00352 1/20 0.43
▸ POLB P06746 1/20 0.43
▸ SOS1 Q07889 2/20 0.41
▸ TLR8 Q9NR97 1/20 0.40
▸ NUDT1 P36639 1/20 0.40
▸ BACE1 P56817 1/20 0.40
▸ TNF P01375 1/20 0.40
▸ CXCL8 P10145 1/20 0.40
▸ NOD2 Q9HC29 1/20 0.40
▸ NOD1 Q9Y239 1/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ PRKACA P17612 1/20 0.37
▸ RPS6KB1 P23443 1/20 0.37
▸ PTGS2 P35354 1/20 0.37
▸ HSD17B10 Q99714 1/20 0.37
▸ ILK Q13418 1/20 0.36
▸ CSF1R P07333 4/20 0.35
▸ CYP1A2 P05177 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8284620 0.90 SOS1 (0.41) RPS6KA5HTTALDH1A1POLBSOS1
SCHEMBL8284697 0.81 KDM4E (0.46) RPS6KA5HTTALDH1A1POLBSOS1
SCHEMBL12226885 0.79 ALDH1A1 (0.49) RPS6KA5HTTALDH1A1POLBCSF1R
SCHEMBL8284623 0.79 HTT (0.40) HTTALDH1A1POLBSOS1TLR8
SCHEMBL30581414 0.77 POLB (0.49) RPS6KA5HTTALDH1A1POLBSOS1
SCHEMBL8285686 0.77 SOS1 (0.49) RPS6KA5HTTALDH1A1POLBSOS1
SCHEMBL8284622 0.76 SIRT2 (0.50) HTTALDH1A1KMT2AHSD17B10KDM4E
SCHEMBL8284616 0.76 TLR8 (0.57) HTTALDH1A1POLBSOS1TLR8
SCHEMBL21310846 0.75 RPS6KA5 (0.47) RPS6KA5HTTALDH1A1POLBSOS1
SCHEMBL8286215 0.74 CSF1R (0.57) HTTALDH1A1POLBCSF1RNTRK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8044073-B2 Aminobenzimidazoles and benzimidazoles as inhibitors of respiratory syncytial virus replication TIBOTEC PHARMACEUTICALS (IE) 2011-10-25 — — US disclosed
US-8044073-B2 Aminobenzimidazoles and benzimidazoles as inhibitors of respiratory syncytial virus replication TIBOTEC PHARMACEUTICALS (IE) 2011-10-25 — — US disclosed
US-20070099924-A1 Aminobenzimidazoles and benzimidazoles as inhibitors of respiratory syncytial virus replication JANSSEN SCIENCES IRELAND UC (IE) 2007-05-03 — — US disclosed
US-20070099924-A1 Aminobenzimidazoles and benzimidazoles as inhibitors of respiratory syncytial virus replication JANSSEN SCIENCES IRELAND UC (IE) 2007-05-03 — — US disclosed
WO-2005058869-A1 AMINOBENZIMIDAZOLES AND BENZIMIDAZOLES AS INHIBITORS OF RESPIRATORY SYNCYTIAL VIRUS REPLICATION TIBOTEC PHARMACEUTICALS LTD. (IE) 2005-06-30 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070099924-A1 Aminobenzimidazoles and benzimidazoles as inhibitors of respiratory syncytial virus replication H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, H1-2, H1-4 RPS6KA5 2308/4885HTT 2862/4885ALDH1A1 1319/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback